New ‘budget impact test’ could delay access to new drugs

17 March 2017

Source MS Society:

NICE has approved a new affordability test for drugs, which could delay one in five new treatments becoming available on the NHS by up to 3 years.

The decision will be effective from 1 April in England. It will not affect people in Scotland, Wales or Northern Ireland.

What does the change mean?

Under the current system, drugs approved as cost effective by NICE are available on the NHS within 3 months.

Under the new test, any treatment thought to cost the NHS more than £20m a year in the first 3 years of it being available, could face delays of as much as 3 years.

During this period the new drug would be made available to some people on the NHS through a phased approach designed by NHS England. Read on.

Blog categories: